← k3vl4r
Log inGet started →

NBIX (Neurocrine Biosciences) Price Forecast

AI-generated price forecast for Neurocrine Biosciences (NBIX) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads NBIX as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 163.11. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

163.11

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

NBIX forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-7.29%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called NBIX's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest NBIX news

From the market-news feed the forecasts are read against.

  • Neurocrine Biosciences (NBIX) Stock Still Looks Undervalued As Its 89% Run Draws Focus · Yahoo · Nov 18
  • Why Neurocrine Biosciences (NBIX) Could Be 20% Undervalued On INGREZZA Momentum · Yahoo · Nov 18
  • Neurocrine Biosciences, Inc. (NBIX) Presents at Jefferies Global Healthcare Conference 2026 Transcript · SeekingAlpha · Nov 17
  • Harbour BioMed Appoints Dr. Sanjay Keswani as Scientific Advisor in Neuroscience · Yahoo · Nov 17
  • Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Morgan Stanley Analyst Says · ldr:tickerreport.com · Nov 13

🔒

See the full NBIX forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

NBIX forecast — frequently asked

Will NBIX go up?

K3vl4r's calibrated AI forecast currently reads NBIX as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the NBIX price prediction for 2026?

K3vl4r's model projects NBIX toward $150.54 over the next ~4 weeks, a -7.3% move from $162.38. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

OPKBEAMMRNAREGNFATEPRTANTLAGERNJAZZRXRXNVAXAMGNGILDSUPN

Will NBIX reach…?

Will NBIX reach $200.00?Will NBIX reach $250.00?Will NBIX reach $500.00?Will NBIX reach $1,000?

Or see the full NBIX price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare NBIX

NBIX vs OPKNBIX vs BEAMNBIX vs MRNANBIX vs REGNNBIX vs FATENBIX vs PRTA

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.